High response rate to low-dose rituximab plus high-dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia

Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia

(2013) S. Gudbrandsdottir et al.   BLOOD

Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopenia

(2012) Francesco Zaja et al.   AMERICAN JOURNAL OF HEMATOLOGY

A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia

(2012) D. M. Arnold et al.   BLOOD

Rituximab before splenectomy in adults with primary idiopathic thrombocytopenic purpura: a meta-analysis

(2012) Sophie Auger et al.   BRITISH JOURNAL OF HAEMATOLOGY

Anti-CD20 monoclonal antibodies and their use in adult autoimmune hematological disorders

(2010) Daan Dierickx et al.   AMERICAN JOURNAL OF HEMATOLOGY

Low-dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoimmune cytopenias

(2010) D. Gomez-Almaguer et al.   BLOOD

Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia

(2010) F. Zaja et al.   BLOOD

Low-dose rituximab in adult patients with primary immune thrombocytopenia

(2010) Francesco Zaja et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia

(2010) Zhenyu Li et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Rituximab in Autoimmune Hematologic Diseases: Not Just a Matter of B Cells

(2010) Roberto Stasi   SEMINARS IN HEMATOLOGY

International consensus report on the investigation and management of primary immune thrombocytopenia

(2009) D. Provan et al.   BLOOD

Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database

(2009) W. Marieke Schoonen et al.   BRITISH JOURNAL OF HAEMATOLOGY

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

(2008) F. Rodeghiero et al.   BLOOD

Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura

(2008) F. Zaja et al.   HAEMATOLOGICA

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

(2008) David J Kuter et al.   LANCET